These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 197250)

  • 21. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia.
    Cerny J; Essex M; Rich MA; Hardy WD
    Int J Cancer; 1975 Feb; 15(2):351-65. PubMed ID: 47847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
    Risser R
    J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroleukemia induction by replication-competent type C viruses cloned from the anemia- and polycythemia-inducing isolates of Friend leukemia virus.
    MacDonald ME; Mak TW; Bernstein A
    J Exp Med; 1980 Jun; 151(6):1493-503. PubMed ID: 6247414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a spleen focus-forming virus in erythroleukemic mice infected with a wild-mouse ecotropic murine leukemia virus.
    Langdon WY; Hoffman PM; Silver JE; Buckler CE; Hartley JW; Ruscetti SK; Morse HC
    J Virol; 1983 Apr; 46(1):230-8. PubMed ID: 6298459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous regression of Friend-virus-induced erythroleukemia. VII. The genetic control of regression.
    Dietz M; Fouchey S; Furmanski P
    Int J Cancer; 1981 Mar; 27(3):341-8. PubMed ID: 6945295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment.
    Schuller GB; Morahan PS
    J Natl Cancer Inst; 1979 May; 62(5):1257-60. PubMed ID: 286101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thymectomy and antithymocyte serum on spontaneous regression of Friend virus-induced erythroleukemia.
    Dietz M; Furmanski P; Clymer R; Rich MA
    J Natl Cancer Inst; 1976 Jul; 57(1):91-5. PubMed ID: 1087346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.
    Steeves RA; Eckner RJ; Bennett M; Mirand EA; Trudel PJ
    J Natl Cancer Inst; 1971 Jun; 46(6):1209-17. PubMed ID: 4325930
    [No Abstract]   [Full Text] [Related]  

  • 31. Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.
    Hankins WD; Krantz SB
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5287-91. PubMed ID: 6933561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-induced loss of Friend virus leukemia cell surface antigens occurs during progression of erythroleukemia in F1 mice.
    Doig D; Chesebro B
    J Exp Med; 1978 Nov; 148(5):1109-21. PubMed ID: 281446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of transplantable erythroleukemia cells from mice infected with helper-independent Friend murine leukemia virus.
    Oliff A; Ruscetti S; Douglass EC; Scolnick E
    Blood; 1981 Aug; 58(2):244-54. PubMed ID: 7018622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spleen in Friend leukemia. I. Prolonged survival of leukemic mice after autoimplantation of spleen tissue.
    Levy SB; Rubenstein CB; Friend C
    J Natl Cancer Inst; 1976 Jun; 56(6):1183-8. PubMed ID: 1069138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A follow-up study of the progression or spontaneous regression of leukemia in mouse strains.
    Szöllösi J; Ember I; Trón L; Kertai P
    Cytometry; 1982 Sep; 3(2):110-5. PubMed ID: 6958443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.
    Scher CD
    J Exp Med; 1978 Apr; 147(4):1044-53. PubMed ID: 206644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of some of the biological properties of Friend virus and its pseudotypes.
    Dawson PJ; Fieldsteel AH
    Int J Cancer; 1973 Mar; 11(2):484-93. PubMed ID: 4597858
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice.
    Cerny J; Essex M; Thomas DB
    Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.